This, together with a long-term expected earnings growth rate of 11.29%, instills confidence in investors. The current level compares favorably with the S&P 500’s return of 1.26% over the same time frame. The company gained roughly 3.91%, which is higher than the Zacks categorized Medical/Dental-Supplies sub industry’s addition of almost 3.41%. Per the agreement, the companies would offer the cloud-based platform, FlowJo Envoy alongwith BD FACSymphony, a cell analyzer for their customers.īecton has had an impressive run on the bourse over the past one month. For more information, see global medical technology company, Becton, Dickinson and Company ( BDX Quick Quote BDX - Free Report), popularly known as BD, recently announced that it has entered into an agreement with FlowJo, LLC, a life science informatics and data analysis company. ![]() Their software innovations enable collaboration, discovery, high-throughput analysis, and data leadership in single-cell biology. Based on technology developed at Stanford, the company was founded in 1997 and provides the leading analysis platform for single-cell flow cytometry analysis. For more information about FlowJo Envoy, to request a free trial license, or to get up-to-date training on single-cell data analysis, visit About FlowJo, LLCįlowJo, LLC is a privately-owned life sciences informatics company in Ashland, Oregon. With collaboration and usability in mind, we built a tool that makes complicated processes elegant while streamlining communication,” said Chad Rosenberg, Director of Special Projects at FlowJo, LLC.įlowJo Envoy by FlowJo, LLC is available now. The needs of researchers advancing science have to be the focus. “It is not enough to just build another LIMS. Together with FlowJo ®, the leading single-cell flow cytometry analysis software, and SeqGeq™, a desktop application that gives bench scientists the ability to quickly and efficiently analyze single-cell omics data, FlowJo, LLC now provides both the analysis tools and the means through which to plan and execute a multi-omic experiment. FlowJo Envoy is platform-agnostic and accepts any kind of data, including flow cytometry, scRNA-seq, RNA-seq, imaging, and microarray data, among many others. In addition, it offers rich comment features and subscriptions to workflow updates so that communication about an experiment stays proximal to the details about experimental progress and data. ![]() ![]() Everything uploaded is searchable and organized according to the projects and studies the lab is undertaking. There was no easy-to-use platform to bring all the people, data, and resources together in one place,” says Michael Stadnisky, Ph.D, CEO of FlowJo, LLC.įlowJo Envoy offers a platform enabling researchers to create and edit a workflow, select instruments for each step, assign steps to collaborators, and upload data and all associated files. “After speaking with core managers and scientists in flow cytometry and genomics, we identified a key challenge in operationalizing multi-model experiments that involve several instruments and experts. Presentations describing the powerful combination of the two technologies to drive single-cell biology were presented in the Next-Gen Sequencing Informatics track at Bio-IT World by CEO Michael Stadnisky, Ph.D.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |